Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease: No association found

Journal of Neurology

Volumn 246, Issue 1, 1999, Pages 45-47

  Mercier, G ^a   Turpin, J C ^a   Lucotte, G ^a  

^a HÔPITAL MAISON BLANCHE   (France)

Author keywords

Association studies; Dopamine transporter gene; French population; Parkinson's disease; Variable number tandem repeat polymorphism

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER;

AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FRANCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; CARRIER PROTEINS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENETIC MARKERS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MINISATELLITE REPEATS; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0032965756     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050304     Document Type: Article

References (15)

1. 3H] GBR 12935 binding in vitro to rat striatal membranes: labelling of the dopamine uptake complex. J Neurochem 48 : 1887-1896
2. 2. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR (1992) Mutant debrisoquine hydroxylase genes in Parkinson's disease. Lancet 339 : 1017-1018
3. 3. Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson's disease: clinical and theoretic implications. Ann Neurol 32 : S125-S127
4. 4. Fonne-Pister R, Meyer UA (1988) Xenobiotic and endobiotic inhibitors of cytochrome P-450 db1 function, the target of debrisoquine/sparteine type polymorphism. Biochem Pharmacol 37 : 3829-3835
5. 5. Gelernter J, Kranzler HR, Satel SL, Rao PA (1994) Genetic association between dopamine transporter protein alleles and cocaine induced paranoia. Neuropsychopharmacology 11 : 195-200
6. 6. Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G, Kato S, Takamo T, Yagi G, Asai M (1996) Dopamine transporter gene polymorphism and psychiatric symptoms seen in schizophrenic patients at their first episode. Am J Med Genet 67 : 406-408
7. 7. Kurth JH, Kurth MC, Poduslo SE, Schwanklaus JD (1993) Association of a monoamine oxydase B allele with Parkinson's disease. Ann Neurol 33 : 368-372
8. 8. Le Couteur DG, Leighton PW, McCann SJ, Pond SM (1997) Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease. Mov Disord 12 : 760-763
9. 9. Leighton PW, Le Couteur DG, Pang CCP, McCann SJ, Chan D, Law LK, Path MRC, Kay R, Pond SM, Woo J (1997) The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology 49 : 1577-1579
10. 10. Lucotte G, Turpin JC, Gérard N, Panserat S, Krishnamoorthy R (1996) Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families. Am J Med Genet 67 : 361-365
11. 3H] GBR-12935 binding proteins. Arch Biochem Biophys 276 : 424-432
12. 12. Persico AM, Vandenbergh DJ, Smith SS, Uhl GR (1993) Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry 34 : 265-267
13. 13. Planté-Bordeneuve V, Taussig D, Thomas F, Saïd G, Wood NW, Marsden CD, Harding AE (1997) Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 48 : 1589-1593
14. 14. Sano A, Kondoh K, Kahimoto Y, Kondo I (1993) A 40-nucleotide repeat polymorphism in the human dopamine transporter gene. Hum Genet 91 : 405-406
15. 15. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14 : 1104-1106